Skip to Content
Søg Menu

Høydepunkter fra ESMO 2024 om lungekreft

Bjørn Henning Grønberg, professor ved Institutt for klinisk og molekylær medisin, NTNU, og overlege ved Kreftklinikken, St. Olavs Hospital, perspektiverer studiene på lungekreft ved ESMO 2024 som han finner mest klinisk relevante.
Bjørn H. Grønberg

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Outstanding Results for the Treatment of Lung Cancer

/ Tony Mok
Lungecancer Play the Video 05:08

Urgent Need for More Knowledge About Quality of Life and Symptoms in Cancer Patients over 80 Years of Age

/ Elisabeth Grov Beisland
ESMO24 Play the Video 02:13

Androgen Receptor Pathway Inhibitors (ARPIs) Are Superior to Taxanes for Castrate-Resistant Metastatic Prostate Cancer

/ Henrik Grönberg
ESMO24Prostatacancer Play the Video 02:35
Ingrid Dyvik

The Role of ctDNA in Precision Oncology – New Data from the IMPRESS-Norway Study

/ Ingrid Dyvik
ESMO24 Play the Video 3:00
Jørgen Bjerggaard Jensen

ctDNA-Guided Immunotherapy Shows Promising Results to Reduce Overtreatment and Improve Outcomes for Patients with Bladder Cancer

/ Jørgen Bjerggaard Jensen
ESMO24Blærecancer Play the Video 03:39
Louise Wichmann Matthiessen

Nye positive resultater for behandling af brystcancer fremlagt på ESMO 2024

/ Louise Wichmann Matthiessen
ESMO24Brystcancer Play the Video 03:02
Claus Andrup Kristensen

LBA35: Positive Efficacy for Eftilagimod plus Pembrolizumab in Patients with Head and Neck Squamous Cell Carcinoma

/ Claus Andrup Kristensen
ESMO24 Play the Video 02:43
Daniel Heinrich

Highlights from ESMO 2024: More Intelligent Choice of Treatment in the Future

/ Daniel Heinrich
ESMO24ProstatacancerNyrecancerBlærecancer Play the Video 4:25
Peter Schmid

Addition of Pembrolizumab to Standard Chemotherapy Patients with Early-Stage Triple-Negative Breast Cancer Has the Potential for a New Standard of Care

/ Peter Schmid
ESMO24Brystcancer Play the Video 04:50
Back to top